JL

Jafco Life Science

Asia, Tokyo, Japan, Tokyo

Description

Jafco Life Science is a venture capital firm specialized in early and late stage venture investments.

Investor Profile

Jafco Life Science has made 6 investments, with 0 in the past 12 months and 17% as lead.

Stage Focus

  • Series C (33%)
  • Series Unknown (33%)
  • Series E (17%)
  • Series D (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Therapeutics
  • Biopharma
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jafco Life Science frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Altitude Life Science Ventures
North America, Colorado, United States, Durango
Co-Investments: 1
NB
North America, Maryland, United States, Gaithersburg
Co-Investments: 2
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 2
MB
North America, New York, United States, New York
Co-Investments: 2
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 2
AC
North America, Illinois, United States, Chicago
Co-Investments: 1
Scottish Widows Investment Partnership
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 2
PV
Europe, England, United Kingdom, London
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Jafco Life Science?

Complexa

Pittsburgh, Pennsylvania, United States

Complexa, a biopharmaceutical company, develops therapies for the treatment of inflammatory, and metabolic diseases.

BiotechnologyHealth CareTherapeutics
Series CJul 26, 2017
Amount Raised: $62,000,000
Kythera Biopharmaceuticals

Calabasas, California, United States

Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.

BiopharmaBiotechnologyHealth Care
Series CMay 19, 2008
Amount Raised: $30,000,000
Intercept Pharmaceuticals

New York, New York, United States

Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases.

BiotechnologyHealth CarePharmaceutical
Series UnknownMay 16, 2006
Amount Raised: $41,000,000
ARYx Therapeutics

Fremont, California, United States

ARYx is a pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.

BiotechnologyPharmaceuticalTherapeutics
Series EFeb 10, 2006
Amount Raised: $30,400,000
ARYx Therapeutics

Fremont, California, United States

ARYx is a pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.

BiotechnologyPharmaceuticalTherapeutics
Series DJun 1, 2004
Amount Raised: $55,000,000
Catalyst Biosciences

South San Francisco, California, United States

Catalyst Biosciences is a biopharmaceutical company that offers protease therapeutics to address disorders of the coagulation system.

BiopharmaBiotechnologyLife SciencePharmaceutical
Series UnknownMar 20, 2003
Amount Raised: $60,000,000